http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0151489-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_310b28d6fcf98b1a5ce665059c1febb6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_766cb7107ac6a33fa8e7e6e3cc84e7e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa850b9f7b785fc5b8d6e02564fed720
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
filingDate 2001-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_140c8f67bc6deb0bca943cabfa105420
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7955249b60e6fe622e5dd08c832dd6e6
publicationDate 2001-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0151489-A3
titleOfInvention Methods for lowering uric acid levels
abstract Disclosed are methods of reducing serum uric acid levels, the methods comprising administration of substituted indolealkanoic acids to patients in need of such treatment. Also disclosed are such compounds useful in the treatment of gout and related diseases. Also disclosed are pharmaceutical compositions containing the compounds.
priorityDate 2000-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4363912-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9603376-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226771291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66689563

Total number of triples: 21.